Increased levels of soluble fms-like tyrosine kinase-1 are associated with adverse outcomes in pregnant women with COVID-19. Torres-Torres J, Espino-Y-Sosa S, Poon LC, Solis-Paredes JM, et al. Ultrasound Obstet Gynecol 2021 Oct 19. doi: 10.1002/uog.24798.

Read + Share

Amedeo Smart

Independent Medical Education

Torres-Torres J, Espino-Y-Sosa S, Poon LC, Solis-Paredes JM, et al. Increased levels of soluble fms-like tyrosine kinase-1 are associated with adverse outcomes in pregnant women with COVID-19. Ultrasound Obstet Gynecol 2021 Oct 19. doi: 10.1002/uog.24798.
PMID: 34664753